SCHEMBL7657817

SCHEMBL7657817

CCOC(=O)c1ccc2nc(C)n(Cc3ccc(OCC)cc3Cl)c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.51
PDE2A O00408 2/20 0.45
PDE10A Q9Y233 1/20 0.45
MAPT P10636 5/20 0.43
NPSR1 Q6W5P4 1/20 0.43
NPC1 O15118 1/20 0.43
NLRP3 Q96P20 1/20 0.43
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
SIRT3 Q9NTG7 1/20 0.41
TP53 P04637 1/20 0.41
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
DCTPP1 Q9H773 1/20 0.41
ALOX5AP P20292 1/20 0.41
RAB9A P51151 2/20 0.40
GALR3 O60755 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6301191 0.93 PPARG (0.55) PPARGPDE2APDE10AMAPTNPSR1
SCHEMBL6301570 0.93 PPARG (0.51) PPARGPDE2APDE10AMAPTNPSR1
SCHEMBL6303866 0.92 PPARG (0.51) PPARGPDE2APDE10AMAPTNPC1
SCHEMBL6394789 0.92 PPARG (0.49) PPARGPDE2APDE10AMAPTNPSR1
SCHEMBL6308646 0.92 PPARG (0.56) PPARGPDE2APDE10AMAPTNPSR1
SCHEMBL6301337 0.91 PPARG (0.51) PPARGMAPTALDH1A1KDM4EDCTPP1
SCHEMBL6307980 0.91 PPARG (0.55) PPARGPDE2APDE10AMAPTNPSR1
SCHEMBL6304029 0.91 PPARG (0.55) PPARGPDE2APDE10AMAPTNPSR1
SCHEMBL6488294 0.90 PPARG (0.42) PPARGPDE2AMAPTNPSR1NPC1
SCHEMBL7657849 0.90 PPARG (0.46) PPARGPDE2APDE10AMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420409-B1 GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 US disclosed
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 EP disclosed